Althira (ATHA) $2.50, is Latest Alzheimer’s Trial Victim. Down 70%

Nearly 100 Alzheimer’s programs have failed in the past decade. Biotech investors should study or at least become...

Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.

CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...

Former Tesla Foundation Vice Chairman Joins StHealth BDC.

St Health Capital Investment Corporation is delighted to announce Dr. Robert GW Brown FAPS, FIEE, FInstP, MAE as a key new member to our board...

FDA Approval for Provention Bio (PRVB).

Re-cork the Champagne! We were contemplating (dreaming) about an opening price over $12, and then a drift up...

Dicerna (DRNA) up 78% Today. Being Acquired by Novo Nordisk (NVO) for $38.00.

We shoot and we score. Up 1,133% since adding to Watch List @ $3.00. Our second...

Ardelyx (ARDX) Reports First Quarter 2024 Showing $204 Million in Cash!

When we added Ardelyx (ARDX) to the Watch List in November of 2022, the market cap near $80 million. Now it's...

Telehealth: iRhythm Technologies, Inc. (IRTC) Opening Down $43 (32%).

Let the dust settle or catch the falling knife? Down from a peak of $270, it's been a difficult...
Biotech Stock Review. Citius, CTXR

More Great News From Citius Pharma (CTXR).

UPDATED CHART 6-15-21 Mino-Lok® Phase III, FDA NewsRussell 2000 Index NewsTechnical Breakout News

Photos: Aphex BioCleanse Systems.

We had the opportunity to visit the Aphex BioCleanse Systems manufacturing facility on 8-18-2020. Truly impressive seeing tanks readying for shipment, and...
Zappy Zapolin, Chad Harman, Kevin Harrington, Psychedelic Stock Review

Psycheceutical’s (BWVI) Delivery Tech is Grabbing Attention. Will Pharma Listen?

A startup’s psychedelic delivery tech is grabbing attention. Will pharma listen? PharmaVoice Psycheceutical is developing a back-of-the-neck topical treatment...

Latest article

Ardelyx (ARDX) Reports First Quarter 2024 Showing $204 Million in Cash!

When we added Ardelyx (ARDX) to the Watch List in November of 2022, the market cap near $80 million. Now it's...

GeoVax to Provide Corporate Update on Tuesday May 14, 2024.

Still our favorite biotech microcap, still our favorite management team, and our favorite risk to reward idea with a $4 million market...

NovaVax (NVAX) Roars Higher, Gaining 225% a $1.2 Billion Increase, at the Blink of...

Sanofi (SNY) Announces Partnership - $500 Million Upfront, plus $700 million in Milestones with NovaVax (NVAX). And some investors say Covid is...